Medtech Insight - News And Expert Analysis For Medtech Decision Makers since 1975

Medical technology firm HeartBeam and leading heart hospital Mount Sinai want to expand cardiac monitoring capabilities. To achieve this, they are collaborating to advance next-generation AI-ECG technology beyond clinical settings. The joint effort illustrates the growing significance of remote pati

Viome Life Sciences needs to update advertising for its CancerDetect Oral & Throat at-home test to clarify that the test detects cancer biomarkers but cannot diagnose cancer, the Advertising Division said after a recent review. However, the NAD allowed most of the company's advertising to stand.

Patients using an algorithm that analyzes data from a continuous glucose monitor to generate insulin dosing recommendations managed their glucose better than patients who self-monitored, a new study has found.

Medtech leaders expect dealmaking to rebound in 2026, but buyers are more selective. Buyers are focused on high-value assets, and AI must prove real clinical and commercial value.

Ultrahuman is back in the US – five months after a patent ruling forced it out. The Ring Pro is redesigned, the pricing model is subscription-free, and the market it is returning to has more competition than the one it left. The real test starts May 15.

Renewal of the Swiss-EU Mutual Recognition Agreement for medical devices may still be a year or two away, but momentum towards ratification was maintained in March when Swiss and EU political leaders signed the final outstanding agreements of the Bilaterals III sectoral agreements.